Jump Financial’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Jump Financial’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$48.8K	Buy	+19,833	New	+$66.4K	﹤0.01%	1791
2021 Q3	–	Sell	-5,438	Closed	-$456K	–	1276
2021 Q2	$456K	Buy	+5,438	New	+$359K	0.04%	510
2021 Q1	–	Sell	-7,856	Closed	-$370K	–	1094
2020 Q4	$370K	Buy	7,856 +2,556	+48%	+$101K	0.06%	507
2020 Q3	$249K	Buy	+5,300	New	+$175K	0.05%	558

Other funds holding NBP

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

ACM

AIHC Capital Management Central $120M AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jump Financial's NBP Position: Q1 2026 in Review

Jump Financial opened a new position in NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2026: 19,833 shares worth $48.8K. The stake represents ﹤0.01% of the portfolio and ranks #1791 among its holdings. This is a return to the name: Jump Financial previously reported a position in NBP as recently as Q2 2021.

Jump Financial first reported a position in NBP in Q3 2020 and has held it in 4 quarters since. The position peaked at $456K in Q2 2021. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

Jump Financial held 19,833 shares of NovaBridge Biosciences American Depositary Shares worth $48.8K as of Q1 2026.
NovaBridge Biosciences American Depositary Shares was a new Jump Financial position in Q1 2026.
NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Jump Financial's portfolio in Q1 2026, its #1791 holding.
Jump Financial first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2020 and has held it in 4 quarters since.
Jump Financial's NovaBridge Biosciences American Depositary Shares position peaked at $456K in Q2 2021.
48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.